| 产品目录 |
|
|
 |
|
|
 |
| Burkitts淋巴瘤细胞系 CA46 |
|
CRL-1648 Burkitts淋巴瘤细胞系 CA46
|
CRL-1648™ |
|
|
|
CA46 |
|
IT Magrath |
|
IgM; kappa light chain |
|
|
| Biosafety Level: |
1 |
|
frozen |
| Medium & Serum: |
See Propagation |
|
suspension |
|
Homo sapiens (human) |
|
lymphoblast
|
|
Disease: Burkitt's lymphoma
Cell Type: B lymphocyte; |
|
immunoglobulin (surface and secreted) |
|
In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location. |
|
| Related Cell Culture Products |
|
complement |
|
HLA B27 (the patient was HLA A2, A11, B17, B27) |
|
Amelogenin: X
CSF1PO: 10,12
D13S317: 8,12
D16S539: 11,12
D5S818: 13
D7S820: 11,12
THO1: 7,9
TPOX: 8,9
vWA: 15,16 |
|
46, XO, XY, dup1(q21-32), t(8;14) (8pter --> 8q23 :: 14q32 --> 14qter; 14pter --> 14q32 :: 8q23 --> 8qter), 13q+, +16 |
|
male |
|
ATCC complete growth medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 20%.
Temperature: 37.0°C |
|
Medium Renewal: Every 2 to 3 days
Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 2 to 3 X 10 exp5 viable cells/ml.
A saturation density of 2 X 10 exp6 is obtainable. |
|
culture medium 95%; DMSO, 5% |
|
16 hrs |
|
Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2001
recommended serum:ATCC 30-2020 |
|
1093: Benjamin D, et al. Immunoglobulin secretion by cell lines derived from African and American undifferentiated lymphomas of Burkitt's and non-Burkitt's type. J. Immunol. 129: 1336-1342, 1982. PubMed: 6286763
22548: Magrath IT, et al. Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. I. Physical, cytogenetic, and growth characteristics. J. Natl. Cancer Inst. 64: 465-476, 1980. PubMed: 6243721
22549: Magrath IT, et al. Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. II. Surface markers. J. Natl. Cancer Inst. 64: 477-483, 1980. PubMed: 6243722 | |
 |
|
|
